Biological similarities between murine chemical-induced 
and natural human bladder carcinogenesis

Palmeira,Carlos; Oliveira,Paula A.; Lameiras,Catarina; Amaro,Teresina; Silva,Victor M.; Lopes,Carlos; Santos,Lúcio

doi:10.3892/ol_00000066

Biological similarities between murine chemical-induced and natural human bladder carcinogenesis

Authors:
- Carlos Palmeira
- Paula A. Oliveira
- Catarina Lameiras
- Teresina Amaro
- Victor M. Silva
- Carlos Lopes
- Lúcio Santos
View Affiliations

Affiliations: Department of Immunology, Portuguese Institute of Oncology, and Health School of University Fernando Pessoa, 4200-072 Porto, Portugal
Published online on: March 1, 2010 https://doi.org/10.3892/ol_00000066
Pages: 373-377

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the similarities between rodent and human urothelial carcinogenesis models using DNA content, p53 and Ki-67 immunoexpression as surrogate markers of bladder carcinogenesis. Following N-butyl-N-(4-hydroxybutyl)-nitrosamine exposure, 49 human cystectomy specimens of bladder cancer and 53 rat bladder specimens were studied. All of the tumours and adjacent mucosa present in each specimen were evaluated. High similarities were observed between the rodent urothelium carcinogenesis process and the corresponding process in humans, in regards to the histopathological features and biological alteration profile: DNA aneuploidy, p53 overexpression and high proliferative index measured by Ki-67 immunoexpression. Despite these similarities, a higher frequency of alterations was observed in earlier stages in the rat chemical-induced carcinogenesis, namely in 5c aneuploid cells, p53 overexpression and higher Ki-67 labelling index. These results confirm that this experimental animal model is a suitable and reproducible model of bladder carcinogenesis, particularly in regards to high-risk non-invasive and invasive urothelial carcinomas. These features mandate its use in the identification of new molecular targets and evaluation of tumour response to new cytotoxic drugs or drug combinations in bladder cancer therapeutic intervention.

View Figures

View References

1	Höglund M: Bladder cancer, a two phased disease? Semin Cancer Biol. 17:225–232. 2007.
2	Crallan RA, Georgopoulos NT and Southgate J: Experimental models of human bladder carcinogenesis. Carcinogenesis. 27:374–381. 2006. View Article : Google Scholar : PubMed/NCBI
3	Oliveira PA, Colaço A, De la Cruz PLF and Lopes C: Experimental bladder carcinogenesis-rodent models. Exp Oncol. 28:2–11. 2006.PubMed/NCBI
4	Arentsen HC, Hendricksen K, Oosterwijk E and Witjes JÁ: Experimental rat bladder urothelial cell carcinoma models. World J Urol. 27:313–317. 2009. View Article : Google Scholar : PubMed/NCBI
5	Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GF, Hill DL and Seibert K: Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res. 60:5599–5602. 2000.PubMed/NCBI
6	Oliveira PA, Palmeira C, Lourenço LM and Lopes CA: Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Exp Clin Cancer Res. 24:609–616. 2005.PubMed/NCBI
7	Williams PD, Lee JK and Theodorescu D: Molecular credentialing of rodent bladder carcinogenesis models. Neoplasia. 10:838–846. 2008.PubMed/NCBI
8	Druckrey H, Preussmann R, Ivankovic S, Schmidt CH, Mennel HD and Stahl KW: Selective induction of bladder cancer in rats by dibutyl-and N-butyl-n-(4-hydroxybutyl)nitrosamine. Z Krebsforsch. 66:280–290. 1964.PubMed/NCBI
9	Kunze E, Schauer A and Schatt S: Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats. Z Krebsforch Klin Onkol Cancer Res Clin Oncol. 87:139–160. 1976.PubMed/NCBI
10	Oliveira PA, Palmeira C, Colaço A, De La Cruz PLF and Lopes C: DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin. Anticancer Res. 26:2995–3004. 2006.PubMed/NCBI
11	Palmeira C, Oliveira PA, Arantes-Rodrigues R, Colaço A, De la Cruz PLF, Lopes C and Santos L: DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis. Oncol Rep. 21:247–252. 2009.PubMed/NCBI
12	Palmeira C, Lameiras C, Amaro T, Lima L, Kock A, Lopes C, Oliveira PA and Santos L: CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa. Urol Oncol. Oct 23–2009.(Epub ahead of print).
13	Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual. 6th edition. Springer Verlag; New York: 2002, View Article : Google Scholar
14	Sauter G, Algaba F, Amin M, et al: Tumours of the urinary system: non-invasive urothelial neoplasias. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JL and Sesterhenn I: IARCC Press; Lyon: pp. 110–123. 2004
15	Lopez-Beltran A, Sauter G, Gasser T, et al: Tumours of the urinary system: infiltrating urothelial carcinoma. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JL and Sesterhenn I: IARCC Press; Lyon: pp. 93–109. 2004
16	Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, Oliveira J, Criado B and Lopes C: Ki-67 index enhances the prognostic accuracy of the urothelial supeficial bladder carcinoma risk group classification. Int J Cancer. 105:267–272. 2003. View Article : Google Scholar : PubMed/NCBI
17	Palmeira CA, Oliveira PA, Seixas F, Pires MA, Lopes C and Santos L: DNA image cytometry in bladder cancer: state of the art. Anticancer Res. 28:443–450. 2008.PubMed/NCBI
18	Cordon-Cardo C: Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol. 42:S154–S165. 2008. View Article : Google Scholar
19	Lacy S, Lopez-Beltran A, MacLennan GT, Foster SR, Montironi R and Cheng L: Molecular pathogenesis of urothelial carcinoma – the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal Quant Cytol Histol. 31:5–16. 2009.
20	Margulis V, Lotan Y, Karakiewicz PI, et al: Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst. 101:114–119. 2009. View Article : Google Scholar : PubMed/NCBI
21	Spiess PE and Czerniak B: Dual-track pathway of bladder carcinogenesis. Practical implications. Arch Pathol Lab Med. 130:844–852. 2006.PubMed/NCBI